Found 1 results
Filters: Author is N. Buyru  [Clear All Filters]
B. Yogurtcu, Hatemi, I., Aydin, I., and Buyru, N., NPRL2 gene expression in the progression of colon tumors, vol. 11, pp. 4810-4816, 2013.
Ahmed FE (2006). Gene-gene, gene-environment & multiple interactions in colorectal cancer. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 24: 1-101. PMid:16690537   Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, et al. (1998). A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58: 5248-5257. PMid:9823339   Braga E, Pugacheva E, Bazov I, Ermilova V, et al. (1999). Comparative allelotyping of the short arm of human chromosome 3 in epithelial tumors of four different types. FEBS Lett. 454: 215-219.   Chung CK, Zaino RJ and Stryker JA (1982). Colorectal carcinoma: evaluation of histologic grade and factors influencing prognosis. J. Surg. Oncol. 21: 143-148. PMid:7132366   Ferlay J, Shin HR, Bray F, Forman D, et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127: 2893-2917. PMid:21351269   Grady WM (2004). Genomic instability and colon cancer. Cancer Metastasis Rev. 23: 11-27. PMid:15000146   Imreh S, Klein G and Zabarovsky ER (2003). Search for unknown tumor-antagonizing genes. Genes Chromosomes Cancer 38: 307-321. PMid:14566849   Jemal A, Siegel R, Ward E, Hao Y, et al. (2009). Cancer statistics, 2009. CA Cancer J. Clin. 59: 225-249. PMid:19474385   Ji L, Nishizaki M, Gao B, Burbee D, et al. (2002). Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res. 62: 2715-2720. PMid:11980673 PMCid:3478680   Kok K, Naylor SL and Buys CH (1997). Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv. Cancer Res. 71: 27-92.   Lazo PA (1999). The molecular genetics of cervical carcinoma. Br. J. Cancer 80: 2008-2018. PMid:10471054 PMCid:2374277   Lerman MI and Minna JD (2000). The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res. 60: 6116-6133. PMid:11085536   Li J, Wang F, Haraldson K, Protopopov A, et al. (2004). Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C. Cancer Res. 64: 6438-6443. PMid:15374952   Maitra A, Wistuba II, Washington C, Virmani AK, et al. (2001). High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am. J. Pathol. 159: 119-130.   Otani S, Takeda S, Yamada S, Sakakima Y, et al. (2009). The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor. J. Surg. Oncol. 100: 358-363. PMid:19274676   Petursdottir TE, Thorsteinsdottir U, Jonasson JG, Moller PH, et al. (2004). Interstitial deletions including chromosome 3 common eliminated region 1 (C3CER1) prevail in human solid tumors from 10 different tissues. Genes Chromosomes Cancer 41: 232-242. PMid:15334546   Protopopov A, Kashuba V, Zabarovska VI, Muravenko OV, et al. (2003). An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Cancer Res. 63: 404-412. PMid:12543795   Schenk PW, Brok M, Boersma AW, Brandsma JA, et al. (2003). Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill. Mol. Pharmacol. 64: 259-268. PMid:12869630   Senchenko VN, Liu J, Loginov W, Bazov I, et al. (2004). Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 23: 5719-5728. PMid:15208675   Senchenko VN, Anedchenko EA, Kondratieva TT, Krasnov GS, et al. (2010). Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer. BMC Cancer 10: 75. PMid:20193080 PMCid:2841140   Shiomi H, Sugihara H, Kamitani S, Tokugawa T, et al. (2003). Cytogenetic heterogeneity and progression of esophageal squamous cell carcinoma. Cancer Genet. Cytogenet. 147: 50-61.   Ueda K, Kawashima H, Ohtani S, Deng WG, et al. (2006). The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells. Cancer Res. 66: 9682-9690. PMid:17018626   Wheeler JM, Bodmer WF and Mortensen NJ (2000). DNA mismatch repair genes and colorectal cancer. Gut 47: 148-153. PMid:10861278 PMCid:1727951   Wistuba II, Behrens C, Virmani AK, Mele G, et al. (2000). High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 60: 1949-1960. PMid:10766185   Yi Lo PH, Chung Leung AC, Xiong W, Law S, et al. (2006). Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas. Cancer Lett. 234: 184-192. PMid:15885884